medical/surgical Acute Respiratory Distress Syndrome (ARDS) secondary to severe sepsis and Disseminated Intravascular Coagulation (DIC) study - Nursing Case Study

Pathophysiology

• Primary mechanism: Severe sepsis triggers an exaggerated inflammatory response, leading to widespread endothelial damage in the lungs. This damage increases capillary permeability, causing pulmonary edema and impaired gas exchange, hallmark features of ARDS.

• Secondary mechanism: The systemic inflammatory response also activates the coagulation cascade, contributing to Disseminated Intravascular Coagulation (DIC). Microthrombi formation and consumption of clotting factors exacerbate tissue hypoxia and further endothelial injury, worsening ARDS.

• Key complication: The combination of impaired gas exchange and systemic coagulopathy results in severe hypoxemia, multi-organ dysfunction, and heightened mortality risk, necessitating aggressive supportive care.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Obstructive Pulmonary Disease (COPD)

• Current medications: Metformin, Lisinopril, Salbutamol inhaler

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe shortness of breath and fever

• Key symptoms: Acute dyspnea, productive cough with purulent sputum, high fever, confusion, decreased urine output, and bruising

• Vital signs: Temperature 39.5°C (103.1°F), Heart Rate 130 bpm, Respiratory Rate 35 breaths per minute, Blood Pressure 85/50 mmHg, Oxygen Saturation 82% on 15L/min non-rebreather mask

Section 1

As the medical team continues to assess the patient, new diagnostic results indicate a worsening clinical picture. Laboratory findings reveal markedly elevated inflammatory markers, with a C-reactive protein (CRP) level of 220 mg/L and procalcitonin level of 15 ng/mL, indicating a severe systemic inflammatory response. Arterial blood gas analysis shows severe hypoxemia with a PaO2 of 55 mmHg and a PaCO2 of 60 mmHg, confirming respiratory acidosis. Additionally, the patient's complete blood count highlights thrombocytopenia with platelets at 45,000/µL, and coagulation studies demonstrate prolonged prothrombin time (PT) of 22 seconds and activated partial thromboplastin time (aPTT) of 60 seconds. Fibrin degradation products, including D-dimer, are significantly elevated, consistent with ongoing DIC.

The patient's renal function is deteriorating, with serum creatinine rising to 2.5 mg/dL and blood urea nitrogen (BUN) at 45 mg/dL, indicative of acute kidney injury secondary to sepsis and hypoperfusion. Liver function tests reveal elevated transaminases, with AST at 120 U/L and ALT at 140 U/L, suggesting hepatic involvement due to hypoxic liver injury. A chest X-ray shows bilateral infiltrates consistent with ARDS, while an ultrasound of the abdomen rules out obstructive causes of renal impairment but shows signs of hepatic congestion.

These diagnostic results necessitate an escalation in care. The patient is intubated and mechanically ventilated in an attempt to improve oxygenation, with settings adjusted for lung-protective ventilation strategies. Continuous renal replacement therapy (CRRT) is initiated to manage acute renal failure and fluid overload. The healthcare team, aware of the patient's penicillin allergy, selects a broad-spectrum antibiotic regimen consisting of meropenem and vancomycin to target potential multidrug-resistant organisms. The critical nature of the situation prompts frequent reassessments and collaboration among the multidisciplinary team to anticipate and address potential complications, such as worsening coagulopathy or the need for vasopressor support to stabilize hemodynamics.

Section 2

As the medical team continues to monitor the patient, they observe a sudden change in the patient's hemodynamic status. Despite ongoing fluid resuscitation and broad-spectrum antibiotic therapy, the patient becomes hypotensive with a blood pressure dropping to 78/45 mmHg. Heart rate increases to 125 beats per minute, and the central venous pressure (CVP) reads low at 4 mmHg, indicating potential intravascular volume depletion. Despite mechanical ventilation, oxygen saturation remains critically low at 85%, leading to further adjustments in ventilator settings and an increase in FiO2 to 100%. The patient also exhibits decreased urine output, now measuring less than 10 mL/hour, highlighting worsening renal perfusion.

In response to these alarming changes, the team initiates norepinephrine infusion to address the refractory hypotension and maintain mean arterial pressure (MAP) above 65 mmHg. However, despite vasopressor support, the patient's lactate level rises to 5 mmol/L, suggesting ongoing tissue hypoperfusion and possibly inadequate cardiac output. A bedside echocardiogram reveals decreased left ventricular ejection fraction at 35%, raising concerns of septic cardiomyopathy as a complicating factor in the patient's clinical course. This finding underscores the complexity of the case and requires careful titration of vasopressors and inotropes to optimize cardiac function without exacerbating myocardial oxygen demand.

With these developments, the multidisciplinary team reassesses the treatment plan, considering the potential need for advanced hemodynamic monitoring with a pulmonary artery catheter to guide fluid and vasopressor management more precisely. The patient's evolving condition prompts discussions about the possibility of extracorporeal membrane oxygenation (ECMO) if conventional interventions fail to stabilize respiratory and hemodynamic parameters. This situation emphasizes the importance of dynamic decision-making and the anticipation of further complications, such as arrhythmias or worsening coagulopathy, necessitating vigilant monitoring and timely therapeutic adjustments.

Section 3

As the team continues to navigate the intricacies of the patient's condition, they decide to implement advanced hemodynamic monitoring to better tailor the treatment strategy. A pulmonary artery catheter is inserted, revealing a cardiac index of 1.8 L/min/m², further confirming inadequate cardiac output. The pulmonary artery wedge pressure is slightly elevated at 18 mmHg, suggesting concurrent left ventricular dysfunction and fluid overload, complicating the fluid resuscitation strategy. Given these findings, the team initiates dobutamine infusion to enhance myocardial contractility and improve cardiac output, carefully balancing the risk of increasing myocardial oxygen demand.

While adjusting the pharmacological interventions, the patient's laboratory results return, indicating worsening coagulopathy. The platelet count has plummeted to 20,000/mm³, and fibrin degradation products are elevated, consistent with the progression of DIC. The team promptly administers platelet transfusions and considers low-dose heparin to mitigate thrombotic complications without exacerbating bleeding risk. Concurrently, renal function continues to decline, evidenced by a rising creatinine level now at 3.2 mg/dL, necessitating discussions about the potential initiation of renal replacement therapy.

Despite these complex interventions, the patient's oxygenation remains critically impaired with a PaO2/FiO2 ratio dropping to 60, indicating severe ARDS. The team is faced with the challenging decision of escalating to ECMO support. This decision involves weighing the benefits of ECMO in providing respiratory and circulatory support against the risks of bleeding in the context of ongoing coagulopathy. The scenario demands robust interdisciplinary collaboration and meticulous clinical judgment to navigate the delicate balance between aggressive intervention and the management of potential complications, all while keeping the family informed and engaged in the decision-making process.

Section 4

As the team continues to manage the patient's precarious condition, a new onset of complications emerges. Overnight, the patient develops signs of worsening respiratory distress, with an increased respiratory rate of 38 breaths per minute and the appearance of paradoxical breathing patterns. Oxygen saturation plummets to 82% despite maximal ventilatory support on high-frequency oscillatory ventilation. Arterial blood gas analysis reveals severe hypoxemia with a PaO2 of 45 mmHg and respiratory acidosis with a pH of 7.25, indicating significant deterioration in respiratory function.

Simultaneously, the patient's hemodynamic status becomes increasingly unstable. Blood pressure fluctuates between 85/50 mmHg and 70/40 mmHg despite ongoing vasopressor support with norepinephrine, and the heart rate remains elevated at 130 beats per minute. The dobutamine infusion has improved cardiac output marginally, but the cardiac index remains low at 2.0 L/min/m². Echocardiography is performed, revealing decreased left ventricular ejection fraction at 30%, suggesting worsening cardiac dysfunction likely exacerbated by ongoing septic shock and myocardial strain.

In light of these developments, the interdisciplinary team convenes to re-evaluate the treatment strategy. The patient’s critical condition necessitates the urgent initiation of ECMO to support both respiratory and cardiac function, with careful consideration given to the elevated bleeding risk due to the ongoing coagulopathy. The decision is made in collaboration with the patient's family, who are briefed on the potential benefits and risks of ECMO. This advanced intervention aims to stabilize the patient, allowing time for other therapeutic measures to address the sepsis and DIC, while the team remains vigilant for any further complications that may arise during this intensive phase of care.

Section 5

As the ECMO circuit is initiated, the clinical team meticulously monitors the patient's response. Initially, there is a slight improvement in oxygenation parameters, with PaO2 rising to 58 mmHg and oxygen saturation increasing to 89%. This marginal improvement provides a glimmer of hope, yet the patient's condition remains critical. Over the next few hours, laboratory results reveal worsening lactic acidosis, with lactate levels climbing to 6.5 mmol/L, indicating severe tissue hypoperfusion despite maximal supportive measures. Concurrently, coagulation profiles show further derangement, with a D-dimer level of 12,000 ng/mL and a platelet count dropping to 25,000/mm³, underscoring the persistent and escalating coagulopathy.

The patient's neurological status also raises concern. Initially sedated for ECMO initiation, upon gradual lightening of sedation, the patient exhibits minimal response to painful stimuli, with a Glasgow Coma Scale score dropping to 6. The team suspects potential cerebral hypoperfusion or microembolic events secondary to the severe DIC, necessitating an urgent CT scan of the head. The interdisciplinary team deliberates on the delicate balance between anticoagulation for ECMO and the risk of intracranial bleeding, a decision compounded by the patient's unstable hemodynamic status.

In the midst of these challenges, the patient's renal function begins to deteriorate, with serum creatinine levels rising to 3.5 mg/dL and urine output decreasing to less than 0.5 mL/kg/hr. This acute kidney injury, likely multifactorial in origin due to septic shock, nephrotoxic medications, and possible microvascular injury from DIC, prompts the nephrology team to consider continuous renal replacement therapy (CRRT). This intervention is proposed to manage fluid overload, correct electrolyte imbalances, and provide renal support in hopes of improving the patient's overall metabolic state. Each step forward in this complex case requires astute clinical judgment, with the team constantly re-evaluating treatment priorities in the face of rapidly evolving complications.